Lysine 322 in the human IgG3 CH2 domain is crucial for antibody dependent complement activation (Q59243312)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Geir Åge Løset

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

4

I Sandlie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

J E Thommesen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

O H Brekke

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

995-1004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

The use of a hapten-Fab conjugate to sensitize target cells for antibody-dependent complement-mediated lysis and antibody-dependent cell-mediated cytotoxicity

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

An IgG primary sequence exposure theory for complement activation using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Activation of complement by an IgG molecule without a genetic hinge

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

The structural requirements for complement activation by IgG: does it hinge on the hinge?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

The C1q receptor site on immunoglobulin G

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

The binding site for C1q on IgG

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Comparison of intact antibody structures and the implications for effector function.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Rapid and efficient site-specific mutagenesis without phenotypic selection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Identification and characterisation of C1q-binding phage displayed peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Functional affinity constants of subfragments of immunoglobulin G for Clq.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Co-operation between the pair of C gamma 2 domains in Clq-binding by rabbit IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

Recombinant mouse monoclonal antibodies with single amino acid substitutions affecting Clq and high affinity Fc receptor binding have identical serum half-lives in the BALB/c mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900010-4

7 January 2021

10.1016/S0161-5890(01)00010-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395138%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference